Services Imbruvica Capsules Exporter

Imbruvica Capsules Exporter

Derek Clarke is a reputable Imbruvica capsules exporter.


Imbuvica (ibrutinib, Pharmacyclics/Janssen Biotech) is indicated to treat the following conditions:

 

 

  • Chronic lymphocytic leukemia (CLL) who have received at least one prior treatment
  • Chronic lymphocytic leukemia (CLL) with 17p deletion
  • Waldenström's macroglobulinemia (WM)
  • Mantle cell lymphoma (MCL) who have received at least one prior treatment


The US Food and Drug Administration (FDA) granted Imbruvica accelerated approval for CLL. CLL is a progressive rare blood and bone marrow disease that causes a gradual increase in white blood cells called B lymphocytes, or B cells.


The FDA’s accelerated approval of Imbruvica for CLL is based on a clinical study of 48 previously treated participants. On average, participants were diagnosed with CLL 6.7 years prior to the study and had received four previous therapies.

 

  • Results showed that after treatment (overall response rate) with Imbruvica, the cancer shrank in nearly 58% of participants. At the time of the study, the duration of response ranged from 5.6 to 24.2 months. An improvement in survival or disease-related symptoms has not been established.


The most common side effects observed in the clinical study include low levels of platelets in the blood (thrombocytopenia), diarrhea, bruising, a decrease in infection-fighting white blood cells (neutropenia), low red blood cells (anemia), upper respiratory tract infection, fatigue, pain in the muscles and bones (musculoskeletal pain), rash, fever (pyrexia), constipation, swelling of tissues (peripheral edema), joint pain (arthralgia), nausea, mouth sores (stomatitis), sinus infection (sinusitis) and dizziness.


Derek Clarke, with more than 30 years as experience as an exporter of both branded and generics medicines, is able to source and supply products, often unavailable through other sources, quickly and efficiently.


For more information on our supplies and exports of Imbruvica capsules please contact us on

 

+44 (0) 208 952 2061